The universities of Tübingen and Munich are collaborating with Hypharm GmbH on the development of HY-133 to combat the dreaded bacterium #Staphylococcus aureus. HY-133 is a highly potent #bacteriophage-derived protein designed to specifically kill this common nasal pathogen.
